Molecular Imaging and Radionuclide Therapy  (formerly Turkish Journal of Nuclear Medicine) is the official publication of Turkish Society of Nuclear Medicine.

Focus and Scope
Molecular Imaging and Radionuclide Therapy (MIRT) (formerly Turkish Journal of Nuclear Medicine) is the official publication of Turkish Society of Nuclear Medicine. MIRT is a double-blind peer-review journal published in English language. It publishes original research articles, reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.   MIRT is published three times a year (April, August, December).
Audience: nuclear medicine physicians, medical physicists, radiopharmaceutical scientists.
The journal is printed on an acid-free paper.

Molecular Imaging and Radionuclide Therapy is indexed in TUBITAK-ULAKBIM, Gale/Cengage Learning, EBSCO databases and Türkiye Atıf Dizini (Turkiye Citation Index).

Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

GENERAL INFORMATION

MIRT commits to rigorous peer review, and stipulates freedom from commercial influence, and promotion of the highest ethical and scientific standards in published articles. Neither the Editor(s) nor the publisher guarantees, warrants or endorses any product or service advertised in this publication. All articles are subject to review by the editors and peer reviewers. If the article is accepted for publication, it may be subjected to editorial revisions to aid clarity and understanding without changing the data presented.
Manuscripts must be written in English and must meet the requirements of the journal. The journal is in compliance with the uniform requirements for manuscripts submitted to biomedical journals published by the International Committee of Medical Journal Editors (NEJM 1997; 336:309-315, updated 2001). Manuscripts that do not meet these requirements will be returned to the author for necessary revision before the review. Authors of manuscripts requiring modifications have a maximum of two months to resubmit the revised text. Manuscripts returned after this deadline will be treated as new submissions.

It is the authors’ responsibility to prepare a manuscript that meets ethical criteria.  The Journal adheres to the principles set forth in the Helsinki Declaration October 2008 (http://www.wma.net/en/30publications/10policies/b3/ index.html) and holds that all reported research involving “Human beings” conducted in accordance with such principles. Reports describing data obtained from research conducted in human participants must contain a statement in the MATERIALS AND METHODS section indicating approval by the ethical review board and affirmation that INFORMED CONSENT was obtained from each participant.

• All manuscripts reporting experiments using animals must include a statement in the MATERIALS AND METHODS section giving assurance that all animals have received humane care in compliance with the Guide for the Care and Use of Laboratory Animals (www.nap.edu) and indicating approval by the ethical review board.
• Case reports should be accompanied by INFORMED CONSENT and the identity of the patient should be hidden.
• Subjects must be identified only by number or letter, not by initials or names. Photographs of patients’ faces should be included only if scientifically relevant. Authors must obtain written consent from the patient for use of such photographs.
• If the proposed publication concerns any commercial product, the author must include in the cover letter a statement indicating that the author(s) has (have) no financial or other interest with the product or explaining the nature of any relations (including consultancies) between the author(s) and editor the manufacturer or distributor of the product.

MANUSCRIPT CATEGORIES

Original Articles
Short Communications
Reviews
Editorials
Case Report and Literature Review
Consensus Statements or Guidelines
Letters to the Editor

Note on Prior Publication
Articles are accepted for publication on the condition that they are original, are not under consideration by another journal, or have not been previously published. Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner and authors. Materials previously published in whole or in part shall not be considered for publication. At the time of submission, authors must report that the manuscript has not been published elsewhere. Abstracts or posters displayed at scientific meetings need not be reported.

MANUSCRIPT SUBMISSION PROCEDURES

MIRT only accepts electronic manuscript submission at the web site www. http://mirt.tsnmjournals.org After logging on to the website Click the  ‘online manuscript submission’ icon.  All corresponding authors should be provided with a password and a username after entering the information required. If you already have an account from a previous submission, enter your username and password to submit a new or revised manuscript. If you have forgotten your username and/or password, please send an e-mail to the editorial office for assistance. After logging on to the article submission system please read carefully the directions of the system to give all needed information and attach the manuscript, tables and figures and additional documents.

All Submissions Must Include: